Furosemide and Haemangioma of skin - a phase IV clinical study of FDA data


Haemangioma of skin is reported only by a few people who take Furosemide.

The phase IV clinical study analyzes which people take Furosemide and have Haemangioma of skin. It is created by eHealthMe based on reports of 274,621 people who have side effects while taking Furosemide from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

274,621 people reported to have side effects when taking Furosemide.
Among them, 2 people (0.0%) have Haemangioma of skin.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 276,851 Furosemide users for its effectiveness, alternative drugs and more.

What is Haemangioma of skin?

Haemangioma of skin (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in the skin or internal organs) is found to be associated with 532 drugs and 277 conditions by eHealthMe.

Number of Furosemide and Haemangioma of skin reports submitted per year:

Could Furosemide cause Haemangioma of skin?

Gender of people who have Haemangioma of skin when taking Furosemide *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Haemangioma of skin when taking Furosemide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Furosemide *:

  1. Vancomycin Hcl: 2 people, 100.00%
  2. Atarax: 2 people, 100.00%
  3. Amlodipine: 2 people, 100.00%
  4. Zolpidem Tartrate: 1 person, 50.00%
  5. Atorvastatin Calcium: 1 person, 50.00%

Common side effects people have besides Haemangioma of skin *:

  1. Toxic Skin Eruption (skin breakdown due to toxic substance): 2 people, 100.00%
  2. Skin Ulcer: 2 people, 100.00%
  3. Rash Morbilliform (a rash that looks like measles): 2 people, 100.00%
  4. Pain: 2 people, 100.00%
  5. Endocarditis Staphylococcal (an inflammation of the inner layer of the heart by staphylococcal bacterial infection): 2 people, 100.00%
  6. Catheter Related Infection: 2 people, 100.00%
  7. Purpura (purplish discoloration of the skin): 1 person, 50.00%
  8. Medical Device Complication: 1 person, 50.00%

Common conditions people have *:

  1. Ill-Defined Disorder: 2 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and have Haemangioma of skin?

Check whether Haemangioma of skin is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Haemangioma of skin and when was it recovered:

Expand to all the drugs that have ingredients of furosemide:

Alternative drugs to, pros and cons of Furosemide:

Common Furosemide side effects:

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Haemangioma of skin treatments and more:

COVID vaccines that are related to Haemangioma of skin:

Common drugs associated with Haemangioma of skin:

All the drugs that are associated with Haemangioma of skin:

Common conditions associated with Haemangioma of skin:

All the conditions that are associated with Haemangioma of skin:

How the study uses the data?

The study uses data from the FDA. It is based on furosemide (the active ingredients of Furosemide) and Furosemide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: